However, the beneficial effects of Angptl4 toward glucose metabolism were counteracted by increased hepatic steatosis, altered liver function profile, hypertriglyceridemia, and hypercholesterolemia [194], probably due to accompanying lipogenesis. The gene discussed is ANGPTL4; the disease is Hypercholesterolemia.